VivoSeq
Other

Intracerebral Haemorrhage

0

Pipeline Programs↗

9

Active Trials↗

1

Companies Involved↗

Intracerebral Haemorrhage is an early-stage landscape with 0 programs across 1 company. The most active players are Novo Nordisk.

Intelligence

Pipeline Metrics

Competitive Density

25/100

Pipeline Velocity

22/100

Mech. Concentration

N/A

Completion Rate

88/100

Attrition Rate

6/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Novo Nordisk logo

Novo Nordisk

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

18

clinical trials

Completed7 · 39%
Recruiting4 · 22%
Not yet recruiting4 · 22%
Unknown status1 · 6%
Active, not recruiting1 · 6%
Terminated1 · 6%

Clinical Trials

Trial Activity

18 trials

Influence of Cerebral Oedema in Intracerebral Haemorrhage
Recruiting·UUniversity Hospital, Lille·N/A·NCT04621357·500 enrolled
Indian Trial of Tranexamic Acid in Spontaneous Intracerebral Haemorrhage
Recruiting·—·Phase 4·NCT05836831·3,400 enrolled
Avoiding Anticoagulation After IntraCerebral Haemorrhage
Recruiting·UUniversity Hospital, Lille·Phase 3·NCT03243175·300 enrolled
NICardipine for Fast Achievement of Systolic BP Targets in ICH - a Quasi-randomized, Implementation Trial With Stepwise Rollout of Nicardipin Based Treatment of Hypertension.
Recruiting·AAarhus University Hospital·Approved·NCT07044232·88 enrolled
A Study to Evaluate the Safety, Tolerability and the Effects of Ixodes Ricinus-Contact Phase Inhibitor (Ir-CPI) in Adult Patients With Spontaneous Intracerebral Haemorrhage
Active, not recruiting·BBioxodes S.A.·Phase 2·NCT05970224·23 enrolled
Reducing the Burden of Cardiovascular Events With Antiplatelet Therapy in Patients With IntraCerebral Haemorrhage
Not yet recruiting·—·Phase 3·NCT07243704·5,676 enrolled
Efficacy of Prophylactic Levetiracetam for Improving Functional Outcome in the Acute Phase of Intracerebral Haemorrhage: a Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Not yet recruiting·HHospices Civils de Lyon·Phase 3·NCT07336992·580 enrolled
DIROXIMEL FUMARATE TO REDUCE PERIHAEMATOMAL OEDEMA IN INTRACEREBRAL HAEMORRHAGE: DOUBLE BLIND RANDOMIZED CLINICAL TRIAL
Not yet recruiting·UUniversity Hospital, Lille·Phase 2·NCT07275515·192 enrolled
Master Study Protocol for the Cohort of the Specialist Network Stroke (SN Stroke) (Stroke-CORE)
Not yet recruiting·CCharite University, Berlin, Germany·N/A·NCT07553650·12,750 enrolled
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
Completed·Novo Nordisk logoNovo Nordisk·Phase 2·NCT00426803·400 enrolled
Safety and Preliminary Efficacy of Activated Recombinant Human Factor VII in Acute Intracerebral Haemorrhage
Completed·Novo Nordisk logoNovo Nordisk·Phase 2·NCT01566786·48 enrolled
BLOC-ICH: Interleukin-1 Receptor Antagonist in Intracerebral Haemorrhage
Completed·—·Phase 2·NCT03737344·25 enrolled
Antiplatelet Secondary Prevention International Randomised Trial After INtracerebral HaemorrhaGe (ASPIRING)-Pilot Phase
Completed·TThe George Institute for Global Health, China·Phase 3·NCT04522102·80 enrolled
International Normalized Ratio (INR) Normalization in Coumadin Associated Intracerebral Haemorrhage
Completed·HHeidelberg University·Phase 4·NCT00928915·54 enrolled
Recombinant Factor VIIa in Acute Intracerebral Haemorrhage
Completed·Novo Nordisk logoNovo Nordisk·Phase 3·NCT00127283·829 enrolled
Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)